POSTER SESSION VI
Wednesday, March 28, 2007   1:00 PM - 4:00 PM
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
BONE AND SOFT TISSUE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
1
Comprehensive Detection of Gene Fusions in Sarcomas and Other Cancers Using Exon-Level Expression Data Obtained by Affymetrix Exon Arrays
(68)
T Motoi, N Socci, A Lash, F Mertens, W Gerald, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY; Lund University Hospital, Lund, Sweden
Molecular Diagnosis of Primitive Neuro-Ectodermal Tumor/Ewing Sarcoma: Comparision of RT-PCR and FISH. A Study of 104 Cases
(77)
R Tirabosco, TC Diss, K Bousdras, AM Flanagan - Royal National Orthopaedic Hospital, Stanmore, United Kingdom; University College London, London, United Kingdom; University College Hospital, London
Biotinyl-Tyramide-Based cRNA In Situ Hybridization: Application to In Situ Detection of SS18-SSX Transcripts in Synovial Sarcoma
(50)
M Hisaoka, A Matsuyama, H Hashimoto - School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan
Detections of FKHR Gene Break-Apart by Fluorescence In Situ Hybridization (FISH) in Formalin Fixed Paraffin Embedded Alveolar Rhabdomyosarcoma
(64)
S Mehra, J Tull, A Shrimpton, G de la Roza, A Valente, S Zhang - SUNY Upstate Medical University, Syracuse, NY
Analysis of 134 Formalin-Fixed Paraffin-Embedded Synovial Sarcomas by Conventional RT-PCR, Real Time RT-PCR and Dual Colour FISH
(28)
MFC Amary, F Berisha, FDC Bernardi, JS Reis-Filho, TC Diss, AM Flanagan - Institute of Orthopaedics, UCL, London, United Kingdom; Santa Casa School of Medical Sciences, Sao Paulo, Brazil; Royal National Orthopaedic Hospital, Middlx; University College Hospital, London; Breakthrough Breast Cancer Research Centre, London
Dermatofibrosarcoma Protuberans COL1A1-PDGFB Fusion Is Identified in Virtually All DFSP Cases When Investigated by Newly Developed Multiplex RT-PCR and FISH Assays
(70)
KU Patel, SS Szabo, V Prieto, AJF Lazar, DH Lopez-Terrada - Baylor College of Medicine, Houston, TX; MD Anderson Cancer Center, Houston, TX
Hemizygous/Homozygous KIT Exon 11 Mutations Indicate Highly Malignant Clinical Behavior of Gastrointestinal Stromal Tumors
(57)
J Lasota, A Wlodarczyk, B Wasag, M Miettinen - Armed Forces Institue of Pathology, Washington, DC; Institute of Oncology, Warsaw, Poland; Medical University of Gdansk, Gdansk, Poland
Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT Negative Phenotype - A Diagnostic Pitfall
(30)
CR Antonescu, JL Hornick, GP Nielsen, M Mino-Kenudson, G Wong, C Corless, CDM Fletcher - Memorial Sloan-Kettering Cancer Center, New York, NY; Brigham & Women’s Hospital, Boston, MA; Massachussetts General Hospital, Boston, MA; Oregon Science & Health University, Portland, OR
Actinin-4 Expression in 187 Cases of Gastrointestinal Stromal Tumor of the Stomach and Intestine: An Immunohistochemical Study
(75)
K Seki, K Honda, T Yamada, U Yamaguchi, Y Suehara, T Shimoda, T Hirohashi - National Cancer Center Hospital, Tokyo, Kazakhstan; National Cancer Center Reserch Insutitute, Tokyo, Japan
Expression of Insulin-Like Growth Factor 2 in Synovial Sarcoma
(34)
D Borys, JB Taxy, R Garcia, H Yee, L Chiriboga, J Wei, MA Greco - NYU School of Medicine, New York, NY; University of Chicago, Chicago, IL
Loss of CXCR4 Nuclear Immunoreactivity in Synovial Sarcoma Correlates with Poor Survival
(38)
AP Dei Tos, S Grisanti, E Rossi, L Ardighieri, VD Ferrari, V Amoroso, L Bercich, G Marini, S Rossi, F Facchetti, F Facchetti - Spedali Civili, Brescia, Italy; University of Brescia School of Medicine, Brescia, Italy; Regional Hospital, Treviso, Italy
Desmoplastic Fibroma: More Clearly Defining This Entity. A Clinicopathologic and Radiologic Study of 58 Cases
(67)
CA Moran, JA Vidal, MD Murphey, M Miettinen, JC Fanburg-Smith - MD Anderson Cancer Center, Houston, TX; Armed Forces Institute of Pathology, Washington, DC
Sex Steroid Receptor, COX-2, and PAI1 Expression in Fibromatosis
(43)
JH Fasig, BW Whited, WD Dupont, SJ Olson, JM Cates - Vanderbilt University Medical Center, Nashville, TN
Tyrosine Kinase Signaling in Fibromatosis
(42)
JH Fasig, BW Whited, WD Dupont, SJ Olson, JM Cates - Vanderbilt University Medical Center, Nashville, TN
Sclerosing Pecoma: Clinicopathologic Analysis of a Distinctive Variant with a Predilection for the Retroperitoneum
(51)
JL Hornick, CDM Fletcher - Brigham and Women’s Hospital, Boston, MA
Clinicopathologic Characteristics of Adult Primary Cardiac Sarcomas: Ten Year Experience with Analysis of 13 Cases
(56)
CH Kim, JY Dancer, MJ Reardon, QJ Zhai, AG Ayala, JY Ro - Weill Medical College Cornell University Medical College, The Methodist Hospital, Houston, TX; College of Medicine, Korea University, Seoul, Korea
Alveolar Soft Part Sarcoma: Review of 71 Cases Treated at a Single Institution
(58)
AJF Lazar, P Das, D Kotilingam, D Lopez-Terrada, C Warneke, D Lev - UT MD Anderson Cancer Center, Houston, TX; UTMDACC, Houston, TX; Texas Children’s Hospital, Houston, TX
D2-40 (Podoplanin) Is a Novel Marker for Follicular Dendritic Cell Sarcoma
(79)
H Yu, JA Gibson, GS Pinkus, JL Hornick - Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Is GLUT-1 a Specific Marker of Perineurial Differentiation? An Evaluation of GLUT-1 Expression in 82 Mesenchymal Tumors
(26)
WA Ahrens, BL Caron, AL Folpe - Mayo Clinic, Rochester, MN
Differential Expression of Syndecan-1 (CD138) in Myxoid Soft Tissue Tumors
(61)
J Liu, HM Haupt, JJ Brooks - Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia, PA
Angioleiomyoma: A Clinicopathologic and Immunohistochemical Reappraisal with Special Reference to the Correlation with Myopericytoma
(63)
A Matsuyama, M Hisaoka, H Hashimoto - University of Occupational & Environmental Health, Kitakyushu, Fukuoka, Japan
CD10 Expression in Epithelioid Hemangioendothelioma: A Preliminary Study
(36)
K Cunningham, D Howarth, B Perez-Ordonez, D Hwang, I Weinreb - University Health Network, Toronto, ON, Canada; Mount Sinai Hospital, Toronto, ON, Canada
Primary Mediastinal Liposarcoma: Clinicopathologic Analysis of 24 Cases
(47)
HP Hahn, CDM Fletcher - Brigham and Women’s Hospital & Harvard Medical School, Boston, MA
Epigenetic Alteration of p16 Is Involved in Dedifferentiation of Liposarcoma
(49)
M He, S Aisner, J Benevenia, F Patterson, T Lin, M Hameed - University of Medicine and Dentistry of New Jersey/New Jersey Medical School, Newark, NJ
Well Differentiated Liposarcoma with Non-Lipogenic Spindle Cell Component: A Review of 33 Cases
(53)
Y Iwasa, Y Nakashima - Rakuwakai Otowa Hospital, Kyoto, Japan; Kyoto University Hospital, Kyoto, Japan
Insulin-Like Growth Factor-I and IGF-I Receptor Are Consistently Expressed in Soft Tissue Liposarcomas
(65)
T Mitsuhashi, M Watanabe, H Sasano, M Ono - Tohoku University Graduate School of Medical Science, Sendai, Miyagi, Japan; Tohoku University Hospital, Sendai, Miyagi, Japan
Evaluation of CD99 Expression in a Large Series of Ewing’s Sarcomas. The Experience of the PROTHETS Group
(62)
A Llombart-Bosch, MM Subramaniam, S Navarro, P Baccini, F Bertoni, N Savelov, JA Lopez-Guerrero - University of Valencia, Valencia, Spain; Istituti Ortopedici Rizzoli, Bologna, Italy; Blockin Cancer Center, Moscow, Russian Federation; Fundacion Instituto Valenciano de Oncologia, Valencia, Spain
p63 Is Expressed in Giant Cell Tumors of Bone
(41)
B Dickson, B Eslami, J Wunder, P Ferguson, R Kandel - Mount Sinai Hospital, Toronto, ON, Canada; Harvard School of Dental Medicine, Boston, MA; Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
EXT and Its Downstream Targets in Central Chondrosarcoma
(74)
YM Schrage, L Hameetman, K Szuhai, AM Cleton-Jansen, AHM Taminiau, PCW Hogendoorn, JVMG Bové - LUMC, Leiden, Netherlands; Leiden University Medical Center, Leiden, Netherlands
EGFR Expression and Copy Number Gain Are Common in Pediatric Osteosarcoma Tumors
(44)
SS Freeman, SW Allen, R Ganti, J Wu, J Ma, X Su, GA Neale, JD Dalton, CA Billups, JS Dome, NC Daw, JD Khoury - St. Jude Children’s Research Hospital, Memphis, TN
Juxtacortical Chondromyxoid Fibroma of Bone: A Unique Variant. A Study of 19 Cases
(32)
AC Baker, L Rezeanu, S O’Laughlin, KK Unni, MJ Klein, GP Siegal - University of Alabama at Birmingham, Birmingham, AL; Mayo College School of Medicine, Rochester, MN; Mt. Sinai, New York, NY
Phosphorylated H2AX Expression in Osteosarcoma and Selected Primary Bone Tumors
(66)
AG Montag, G He, S Chmura, A Khramtsov, M Tretiakova - University of Chicago, Chicago, IL
Is Better Chemotherapy Response in Telangiectatic Osteosarcoma Due to Increased Tumor Vascularization or Higher Proliferation Index? A Comparative Immunohistochemical Study of 20 Cases
(72)
L Rezeanu, AC Baker, GP Siegal, MJ Klein - University of Alabama at Birmingham, Birmingham, AL
Gnathic Well Differentiated Osteosarcomas: A Clinicopathologic Study of 9 Cases
(39)
V Deshpande, GP Nielsen, AE Rosenberg - Massachusetts General Hospital, Boston, MA
The Evaluation of Cell Cycle Proteins (CyclinD1, CyclinD3, P21, P27) and Ki-67 in Giant Cell Lesions of Bone
(45)
A Gokdemir, S Erdogan, M Ergin, S Ozbarlas, G Gonlusen - Cukurova University Medical School, Adana, Turkey
Molecular Imaging of Multidrug Resistance in an Orthotopic Model of Osteosarcoma
(46)
CMF Gomes, M Welling, I Que, NV Henriquez, G van der Pluijm, S Romeo, AJ Abrunhosa, MF Botelho, PCW Hogendoorn, E Pauwels, AM Cleton-Jansen - LUMC, Leiden, Netherlands; IBILI, Coimbra, Portugal
Comparative Gene Expression Profiling of Chordoma and Chondrosarcoma
(25)
NP Agaram, JH Schwab, PJ Boland, ND Socci, T Guo, S Doty, S Ferrone, JH Healey, CR Antonescu - Memorial Sloan-Kettering Cancer Center, New York, NY; Roswell Park Cancer Institute, Buffalo, NY; Sloan-Kettering Institute, New York, NY; The Hospital for Special Surgery, New York, NY